Moss Gregory S. — SEC Form 4 filings
SEC reporting owner CIK 1742496. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-09.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-11-07 to 2026-06-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 14,223 shares, $324,711 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 14,223 shares @ $22.83 ($324,711) in Evommune, Inc., filed 2026-06-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Evommune, Inc. (EVMN) | Chief Business & Legal Officer | 5 | — | 1 leg · 14,223 sh · $324,711 | 7 |
| Anteris Technologies Global Corp. (AVR) | Director | 2 | — | — | 4 |
Form 4 filings — Moss Gregory S.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-09 | 4 | Anteris Technologies Global Corp. (AVR) | Option exercise (M): 17,580 · Option exercise (M): 17,580 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Evommune, Inc. (EVMN) | Option exercise (M): 14,223 @ $1.71 · Sale (S): 14,223 @ $22.83 · Option exercise (M): 14,223 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 115,279 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Evommune, Inc. (EVMN) | Tax withholding (F): 13,624 @ $17.84 | EDGAR |
| 2025-12-05 | 4 | Anteris Technologies Global Corp. (AVR) | Grant/award (A): 52,742 (derivative) @ $0 · Grant/award (A): 13,821 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Evommune, Inc. (EVMN) | Conversion (C): 3,175 · Conversion (C): 25,000 (derivative) | EDGAR |
| 2025-11-07 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 293,496 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742496 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →